SCHEMBL6028249

SCHEMBL6028249

Fc1ccc(-c2nn(CN3CCCC3)cc2-c2ccncc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.56
CSNK1D P48730 5/20 0.56
MAPK13 O15264 4/20 0.56
MAPK12 P53778 4/20 0.56
MAPK11 Q15759 4/20 0.56
CSNK1E P49674 4/20 0.56
BRAF P15056 7/20 0.48
SRC P12931 2/20 0.48
KDR P35968 2/20 0.48
MAP4K4 O95819 3/20 0.41
BMPR1B O00238 2/20 0.41
CIT O14578 2/20 0.41
RIPK2 O43353 2/20 0.41
STK10 O94804 2/20 0.41
ABL1 P00519 2/20 0.41
RAF1 P04049 2/20 0.41
ERBB3 P21860 2/20 0.41
JAK1 P23458 2/20 0.41
ACVR1B P36896 2/20 0.41
TGFBR1 P36897 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27474989 0.81 MAPK14 (0.57) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL6077643 0.79 MAPK14 (0.58) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL5255744 0.79 MAPK14 (0.58) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL1647484 0.79 MAPK14 (0.65) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL6077523 0.79 CSNK1D (0.65) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL16105527 0.79 MAPK14 (0.61) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL1892201 0.79 CSNK1D (0.65) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL1644870 0.79 MAPK14 (0.65) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL1647083 0.78 MAPK14 (0.57) MAPK14CSNK1DMAPK13MAPK12MAPK11
SCHEMBL5448018 0.77 MAPK14 (0.59) MAPK14CSNK1DMAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1281604-C Substituted pyrazole compounds TEIKOKU HORMONE MFG CO LTD (JP) 2006-10-25 CN disclosed
US-7087624-B2 Substituted pyrazole compounds TEIKOJU HORMONE MFG. CO., LTD. (JP) 2006-08-08 US disclosed
EP-1188754-B1 SUBSTITUTED PYRAZOLE COMPOUNDS TEIKOKU HORMONE MFG CO LTD (JP) 2005-06-01 EP disclosed
CN-1560051-A Substituted pyrazole compounds �۹���ҩ��ʽ���� 2005-01-05 CN disclosed
CN-1178931-C Substituted pyrazole compounds �۹���ҩ��ʽ���� 2004-12-08 CN disclosed
US-20040087628-A1 Substituted pyrazole compounds MINAMI NOBUYOSHI (JP) 2004-05-06 US disclosed
US-6667325-B1 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases TEIKOKU HORMONE MFG. CO., LTD. (JP) 2003-12-23 US disclosed
CN-1353704-A Substituted pyrazole compounds TEIKOKU HORMONE MFG CO LTD (JP) 2002-06-12 CN disclosed
EP-1188754-A1 SUBSTITUTED PYRAZOLE COMPOUNDS Teikoku Hormone Mfg. Co., Ltd. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087628-A1 Substituted pyrazole compounds CNKSR1, MAPK1, IRAK1 MAPK14 64/4885CSNK1D 234/4885MAPK13 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.